Cryoelectron tomography of HIV-1 envelope spikes: Further evidence for tripod-like legs

PLoS Pathogens

Volumn 4, Issue 11, 2008, Pages

  Zhu, Ping ^a,b   Winkler, Hanspeter ^a   Chertova, Elena ^c   Taylor, Kenneth A ^a   Roux, Kenneth H ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b INSTITUTE OF BIOPHYSICS   (China)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; CRYOELECTRON MICROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOGENESIS; SPIKE WAVE; VIRION; VIRUS ENVELOPE; VIRUS MORPHOLOGY; CHEMISTRY; ELECTRON MICROSCOPE TOMOGRAPHY; PLIABILITY; ULTRASTRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; VIRUS ENVELOPE PROTEIN;

CRYOELECTRON MICROSCOPY; ELECTRON MICROSCOPE TOMOGRAPHY; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; PLIABILITY;

EID: 57149107577     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000203     Document Type: Article

References (47)

1. Center RJ, Leapman RD, Lebowitz J, Arthur LO, Earl PL, et al. (2002) Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol 76: 7863-7867.
2. Center RJ, Schuck P, Leapman RD, Arthur LO, Earl PL, et al. (2001) Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation. Proc Natl Acad Sci USA 98: 14877-14882.
3. Caffrey M, Cai M, Kaufman J, Stahl SJ, Wingfield PT, et al. (1998) Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J 17: 4572-4584.
4. Doms RW (2000) Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. Virology 276: 229-237.
5. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
6. Zhu P, Chertova E, Bess J, Lifson JD, Arthur LO, et al. (2003) Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc Natl Acad Sci USA 100: 15812-15817.
7. Lorizate M, de la Arada I, Huarte N, Sanchez-Martinez S, de la Torre BG, et al. (2006) Structural analysis and assembly of the HIV-1 gp41 amino-terminal fusion peptide and the pretransmembrane amphipathic-at-interface sequence. Biochemistry 45: 14337-14346.
8. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, et al. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 383: 648-659.
9. Huang C, Tang M, Zhang M, Majeed S, Montabana E, et al. (2005) Structure of a V3-containing HIV-1 gp120 core. Science 310: 1025-1028.
10. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, et al. (2005) Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 433: 834-841.
11. Kwong PD, Dolye ML, Caspar DJ, Cicala C, Leavitt SA, et al. (2002) HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 420: 678-682.
12. Roux KH, Taylor KA (2007) AIDS virus envelope spike structure. Curr Opin Struct Biol 17: 244-252.
13. Gelderblom HR, Hausmann EHS, Ozel M, Pauli G, Koch MA (1987) Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156: 171-176.
14. Gelderblom HR (1991) Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5: 617-637.
15. Grief C, Hockley DJ, Fromholc CE, Kitchin PA (1989) The morphology of simian immunodeficiency virus as shown by negative staining electron microscopy. J Gen Virol 70: 2215-2219.
16. Moore PL, Crooks ET, Porter L, Zhu P, Cayanan CS, et al. (2006) Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J Virol 80: 2515-2528.
17. Bewley CA, Louis JM, Ghirlando R, Clore GM (2002) Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J Biol Chem 277: 14238-14245.
18. Zhu P, Liu J, Bess J, Chertova E, Lifson JD, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441: 847-852.
19. Zanetti G, Briggs JAG, Grunewald K, Sattentau Q, Fuller SD (2006) Cryoelectron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathogens 2: e83. doi:10.1371/journal.ppat.0020083.
20. Chertova E, Crise BJ, Morcock DR, Bess JW, Henderson LE, et al. (2003) Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins. Curr Mol Med 3: 265-272.
21. Rossio JL, Esser MT, Suryanarayana K, Schneider DK, Bess JW, et al. (1998) Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. J Virol 72: 7992-8001.
22. Saxton WO, Baumeister W, Hahn M (1984) Three-dimensional reconstruction of imperfect crystals. Ultramicroscopy 13: 57-70.
23. Winkler H, Taylor KA (2005) Accurate marker-free alignment with simultaneous geometry determination and reconstruction of tilt series in electron tomography. Ultramicroscopy 106: 240-254.
24. Förster F, Medalia O, Zauberman N, Baumeister W, Fass D (2005) Retrovirus envelope protein complex structure in situ studied by cryo-electron tomography. Proc Natl Acad Sci USA 102: 4729-4734.
25. Winkler H, Taylor KA (1999) Multivariate statistical analysis of three-dimensional cross-bridge motifs in insect flight muscle. Ultramicroscopy 77: 141-152.
26. Subramaniam S (2006) The SIV surface spike imaged by electron tomography: one leg or three? PLOS Pathogens 2: e91. doi:10.1371/journal.ppat.0020091.
27. Srivastava IK, Ulmer JB, Barnett SW (2004) Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design. Expert Rev Vaccines 3: S33-S52.
28. Pantophlet R, Burton DR (2006) Gp120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-769.
29. Kwong PD, Wyatt R, Sattentau QJ, Sodroski J, Hendrickson WA (2000) Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol 74: 1962-1972.
30. Douek DC, Kwong PD, Nabel GJ (2006) The rational design of an AIDS vaccine. Cell 124: 677-681.
31. Yuan W, Bazick J, Sodroski J (2006) Characterization of the multiple conformational states of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker. J Virol 80: 6725-6737.
32. Crooks ET, Jiang P, Franti M, Wong S, Zwick MB, et al. (2008) Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization. Virology 377: 364-378.
33. Srivastava IK, Kan E, Sun Y, Sharma VA, Cisto J, et al. (2008) Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates. Virology 372: 273-290.
34. Taylor BM, Foulke JS, Flinko R, Heredia A, DeVico A, et al. (2008) An alteration of HIV gp41 leading to reduced CCR5 dependence and CD4 independence. J Virol 1128: 1049-1107.
35. Gray ES, Moore PL, Bibollet-Ruche F, Li H, Decker JM, et al. (2008) 4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response. J Virol 82: 2367-2375.
36. Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, et al. (2005) Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol 79: 12231-12241.
37. Kodama T, Wooley DP, Naidu YM, Kestler HW III, Daniel MD, et al. (1989) Significance of premature stop codons in env of simian immunodeficiency virus. J Virol 63: 4709-4714.
38. Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, et al. (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22: 163-173.
39. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, et al. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol 78: 10724-10737.
40. Alam SM, McAdams M, Boren D, Rak M, Scearce RM, et al. (2007) The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J Immunol 178: 4424-4435.
41. Brunel FM, Zwick MB, Cardoso RM, Nelson JD, Wilson IA, et al. (2006) Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody. J Virol 80: 1680-1687.
42. Sun ZJ, Oh KJ, Kim M, Yu J, Brusic V, et al. (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28: 52-63.
43. Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RMF, et al. (2007) An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human-immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J Virol 81: 4033-4043.
44. Yuste E, Sanford HB, Carmody J, Bixby J, Little S, et al. (2006) Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific epitopes: replication, neutralization, and survey of HIV-1-positive plasma. J Virol 80: 3030-3041.
45. Zwick MB (2005) The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring. AIDS 19: 1725-1737.
46. Montero M, van Houten NE, Wang X, Scott JK (2008) The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol Molec Biol Rev 72: 54-84.
47. Liu J, Bartesaghi A, Borgnia MJ, Sapiro G, Subramaniam S (2008) Molecular architecture of native HIV-1 gp120 trimers. Nature 455: 109-113.